Ignite Creation Date:
2024-05-06 @ 12:48 PM
Last Modification Date:
2024-10-26 @ 1:04 PM
Study NCT ID:
NCT03855683
Status:
SUSPENDED
Last Update Posted:
2020-09-18
First Post:
2019-02-10
Brief Title:
Stress Anxiety and Mood Group Therapy
Sponsor:
Palo Alto University
Organization:
Palo Alto University
Study Overview
Official Title:
Transdiagnostic Interventions for Emotional Disorders
Status:
SUSPENDED
Status Verified Date:
2020-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Social distancing regulations related to COVID19
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to identify cognitive mechanisms that might facilitate treatment response for individuals experiencing depression andor anxiety The Stress Anxiety and Mood group helps individuals experiencing symptoms of stress anxiety and mood by providing concrete coping skills to regulate emotions to let go of negative thoughts and build courage to talk to others about tough topics Groups meet for 8 weeks with sessions lasting 90 minutes each In addition to group therapy you will be asked to complete some computerized and paper and pencil-based tasks
If you are interested in learning more please contact us at 650-417-2000 ext 3642 or paloaltostudygmailcom All inquiries will be kept strictly confidential
If you are interested in learning more please contact us at 650-417-2000 ext 3642 or paloaltostudygmailcom All inquiries will be kept strictly confidential
Detailed Description:
PRIMARY OBJECTIVES
I Identify specific patterns of executive function impairment that distinguish affective and cognitive symptoms in anxious andor depressed patients
II Identify specific components of executive function that predict Unified Protocol treatment response This will set up subsequent cognitive intervention studies targeting those components
The phone screen includes a confidentiality statement explaining how their information will be kept confidential demographic questions and questions regarding the participants medical and psychiatric history and current psychological state Responses to these questions will be used to determine if the individual meets inclusion criteria to engage in the study If the participant meets study eligibility criteria heshe will be invited to an informational session not exceeding two and a half hours at Dr Warrens lab which involves an explanation the project informed consent some questionnaires and a diagnostic clinical interview Also during the first visit participants will be informed of the upcoming visits and the types of activities they will be asked to engage in for the purposes of this study During a second visit subjects will undergo cognitive testing designed to measure set shifting working memory updating cognitive inhibition processing speed general intelligence and attentional control These tests will be administered at Dr Warrens lab and will not exceed two and a half hours The remainder of the study visits will involve an 8-week cognitive-behavioral group therapy titled Unified Protocol to take place at the Gronowski Clinic Treatment groups will be facilitated by Dr Warren and co-facilitated by trained graduate students selected by Dr Warren
I Identify specific patterns of executive function impairment that distinguish affective and cognitive symptoms in anxious andor depressed patients
II Identify specific components of executive function that predict Unified Protocol treatment response This will set up subsequent cognitive intervention studies targeting those components
The phone screen includes a confidentiality statement explaining how their information will be kept confidential demographic questions and questions regarding the participants medical and psychiatric history and current psychological state Responses to these questions will be used to determine if the individual meets inclusion criteria to engage in the study If the participant meets study eligibility criteria heshe will be invited to an informational session not exceeding two and a half hours at Dr Warrens lab which involves an explanation the project informed consent some questionnaires and a diagnostic clinical interview Also during the first visit participants will be informed of the upcoming visits and the types of activities they will be asked to engage in for the purposes of this study During a second visit subjects will undergo cognitive testing designed to measure set shifting working memory updating cognitive inhibition processing speed general intelligence and attentional control These tests will be administered at Dr Warrens lab and will not exceed two and a half hours The remainder of the study visits will involve an 8-week cognitive-behavioral group therapy titled Unified Protocol to take place at the Gronowski Clinic Treatment groups will be facilitated by Dr Warren and co-facilitated by trained graduate students selected by Dr Warren
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None